What finance podcasts are saying aboutGILEAD SCIENCES, INC.GILDNasdaq
According to Zortix's podcast index, GILEAD SCIENCES, INC. (GILD) was discussed on 1 finance podcast across 1 episode in the 30 days to 27 Aug 2026, generating 2 attributed ideas — most coverage from CNBC Fast Money.
- Mentions · 7d
- 2
- Mentions · 30d
- 2
- Mentions · 90d
- 2
- Episodes · 30d
- 1
- Shows · 30d
- 1
- Vs prior week
- +2
- Discussion depth
- Notable commentary
As of 25 Aug 2026
Ask Zortix about GILDKey facts
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- Headquarters
- Foster City, CA
- Incorporated in
- Delaware
- Fiscal year ends
- 31 December
Listing and registration facts from public registries · SEC EDGAR filings for GILD. Not a rating, forecast or recommendation.
Top shows by coverage · 30 days
| Show | Ideas | Episodes |
|---|---|---|
| CNBC Fast Money | 2 | 1 |
Latest ideas · headlines, attributed
25 AUG2D AGOCNBC FAST MONEY
25 AUG2D AGOCNBC FAST MONEY
3 OCT3 OCT 2025BARRON'S STREETWISE · BIG PHARMA. PLUS
Definitions
- Mention
- One attributed idea naming this ticker, extracted from a podcast episode and dated by the episode’s air date. How we count →
- Attributed idea
- A specific argument a named speaker made on a named show — never an aggregate opinion, never Zortix’s view. What qualifies →
- Discussion depth
- How thoroughly an idea was argued on the episode, from a brief mention to a core thesis — a description of the conversation, not a rating of the stock. The bands →
- Stance mix
- Counts of attributed ideas by the side each argued on this name — bullish, balanced, or bearish as the speaker put it. A tally of the conversation’s sides, never a combined score, a rating, or Zortix’s view.